An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
about
Tackling dengue fever: Current status and challengesMouse models to study dengue virus immunology and pathogenesisUnderstanding the dengue viruses and progress towards their controlDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesDengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibodyNatural Strain Variation and Antibody Neutralization of Dengue Serotype 3 VirusesCross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III.Dengue in India.Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodiesInduction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccineNeutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice.Animal models of dengue virus infectionThe tetravalent formulation of domain III-capsid proteins recalls memory B- and T-cell responses induced in monkeys by an experimental dengue virus infection.Evaluation of extracellular subviral particles of dengue virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens.Dengue virus type-3 envelope protein domain III; expression and immunogenicity.Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope ProteinA tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in MiceRecent Developments in Recombinant Protein-Based Dengue Vaccines
P2860
Q24288867-8B229361-DE1A-4AC5-94C4-DD0C461D84D7Q27010151-22E0AB82-1D90-42EB-B960-1569EFE24F69Q27011587-E6314757-9C89-452F-8940-5175947DC4FBQ27304342-F24F6047-E7D9-435C-BFF5-6C5B4C15B8A7Q27489654-9FB47041-FE1F-4201-84AC-E3BB78392BB1Q27491299-D32915E1-78D9-4617-84D6-D2EA8C3970DEQ34354665-360230D4-4339-4937-8336-82B34F2285ECQ35796610-45550A47-A081-420D-9BEF-90B77D40B261Q36436289-58EE995D-23FC-486B-8BCD-61A5EA0909A3Q36569534-6FB0589A-ACB2-4A62-A681-7B174D8ACA2BQ36667964-DF1EC67C-8C20-44C9-B289-57EEB4A4EF22Q36889041-2D09745B-1A66-44B5-8810-EBFDA1C0F7D3Q37500519-3F941E5D-272A-4D29-A29C-7A5AC8FD6830Q37721304-6AA82FCA-C012-48BF-943E-D1E520AC6C0FQ37987131-B53B50B3-F3D3-40BD-8EEC-B86CC9030E44Q39023330-6284A871-2C81-46B3-8898-1FCE12356A28Q39674249-F18C30A1-1E31-4840-B33E-BEF31C91C4F0Q40168970-D31C4800-2717-4C0F-9B97-B72D9425AAFFQ40280642-4EE6A64A-9E16-42AD-B3E5-4B33FEEC6BCFQ41921198-7BB39050-CCC0-4584-9908-847DB8503F6FQ47194469-E7B67840-E5BC-407E-BA4A-9DE382AA9FDAQ56888687-82E0E5A4-7520-4003-9981-8A52D7B5918CQ56960671-4FB6023B-88D4-4D6F-9CCB-D2808C9D2C0E
P2860
An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
An envelope domain III-based c ...... l four dengue virus serotypes.
@en
An envelope domain III-based c ...... l four dengue virus serotypes.
@nl
type
label
An envelope domain III-based c ...... l four dengue virus serotypes.
@en
An envelope domain III-based c ...... l four dengue virus serotypes.
@nl
prefLabel
An envelope domain III-based c ...... l four dengue virus serotypes.
@en
An envelope domain III-based c ...... l four dengue virus serotypes.
@nl
P2093
P1476
An envelope domain III-based c ...... ll four dengue virus serotypes
@en
P2093
Behzad Etemad
Gaurav Batra
Navin Khanna
Rajendra Raut
Saima Khanam
Sathyamangalam Swaminathan
P304
P356
10.4269/AJTMH.2008.79.353
P407
P577
2008-09-01T00:00:00Z